About Us

Acoustic Wave Cell Therapy, Inc. (AWCT) was founded in 2014 to commercialize a technology platform developed at the University of California, San Francisco (UCSF) by AWCT’s scientific founder, Dr. Tom Lue, and his research team. The research was conducted over 20 years and supported by multiple NIH and DOD grants. Over 65 peer-reviewed scientific articles related to this research have been published. AWCT has exclusive rights to this technology through a license from UCSF. The technology is protected by 21 issued U.S. patents and 9 foreign applications.

AWCT is based in the San Francisco Bay Area and has operations in the Midwest, southern California and Taiwan.

Tom F. Lue, MD, ScD (Hon), FACS – Co-founder;Principal Scientific Advisor.

Dr. Lue is Professor and Emil Tanagho Endowed Chair in Clinical Urology at the University of California San Francisco and medical director of the Knuppe Molecular Urology Laboratory. Dr. Lue is an internationally recognized expert on treatment of male sexual dysfunction and a pioneer in surgical methods to treat refractory ED. His research team proved that PDE5 inhibitors enhance erection in animals, providing the scientific basis for Viagra, Levitra and Cialis. He is also an expert on incontinence and developed the first animal model of female stress urinary incontinence,now used widely to study potential treatments. He is co-inventor of the sacral stimulation method of treating urge incontinence, the technology underlying Medtronic’s Interstim product line. Dr. Lue graduated with highest honors from the Kaohsiung Medical University in Taiwan and completed his urologic training at the State University of New York Downstate Medical Center. He has authored or co-authored twelve books and more than 380 publications. He is the recipient of numerous honors, including the Gold Cystoscope Award from the American Urological Association and an award for most innovative research from the American Foundation of Urologic Disease